These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1282 related items for PubMed ID: 17011951

  • 1. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy.
    Avery RL, Pearlman J, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ, Wendel R, Patel A.
    Ophthalmology; 2006 Oct; 113(10):1695.e1-15. PubMed ID: 17011951
    [Abstract] [Full Text] [Related]

  • 2. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.
    Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ.
    Ophthalmology; 2006 Mar; 113(3):363-372.e5. PubMed ID: 16458968
    [Abstract] [Full Text] [Related]

  • 3. Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study).
    Jorge R, Costa RA, Calucci D, Cintra LP, Scott IU.
    Retina; 2006 Mar; 26(9):1006-13. PubMed ID: 17151487
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Descending doses of intravitreal bevacizumab for the regression of diabetic neovascularization.
    Stergiou PK, Symeonidis C, Dimitrakos SA.
    Acta Ophthalmol; 2011 May; 89(3):218-21. PubMed ID: 19860769
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Repeated intravitreal bevacizumab (Avastin(®)) treatment of persistent new vessels in proliferative diabetic retinopathy after complete panretinal photocoagulation.
    Schmidinger G, Maar N, Bolz M, Scholda C, Schmidt-Erfurth U.
    Acta Ophthalmol; 2011 Feb; 89(1):76-81. PubMed ID: 21272288
    [Abstract] [Full Text] [Related]

  • 8. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
    Kook D, Wolf A, Kreutzer T, Neubauer A, Strauss R, Ulbig M, Kampik A, Haritoglou C.
    Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710
    [Abstract] [Full Text] [Related]

  • 9. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
    Haritoglou C, Kook D, Neubauer A, Wolf A, Priglinger S, Strauss R, Gandorfer A, Ulbig M, Kampik A.
    Retina; 2006 Oct; 26(9):999-1005. PubMed ID: 17151486
    [Abstract] [Full Text] [Related]

  • 10. Intravitreal bevacizumab in the treatment of diabetic ocular neovascularization.
    Ababneh OH, Yousef YA, Gharaibeh AM, Abu Ameerh MA, Abu-Yaghi NE, Al Bdour MD.
    Retina; 2013 Apr; 33(4):748-55. PubMed ID: 23296048
    [Abstract] [Full Text] [Related]

  • 11. Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot study.
    Chan WM, Lai TY, Liu DT, Lam DS.
    Ophthalmology; 2007 Dec; 114(12):2190-6. PubMed ID: 17599414
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Intravitreal bevacizumab (Avastin) in proliferative diabetic retinopathy.
    Minnella AM, Savastano CM, Ziccardi L, Scupola A, Falsini B, Balestrazzi E.
    Acta Ophthalmol; 2008 Sep; 86(6):683-7. PubMed ID: 17995986
    [Abstract] [Full Text] [Related]

  • 14. Intravitreal bevacizumab (avastin) treatment of retinal angiomatous proliferation.
    Ghazi NG, Knape RM, Kirk TQ, Tiedeman JS, Conway BP.
    Retina; 2008 May; 28(5):689-95. PubMed ID: 18463511
    [Abstract] [Full Text] [Related]

  • 15. Intravitreal bevacizumab (avastin) for central and hemicentral retinal vein occlusions: IBeVO study.
    Costa RA, Jorge R, Calucci D, Melo LA, Cardillo JA, Scott IU.
    Retina; 2007 Feb; 27(2):141-9. PubMed ID: 17290194
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up.
    Arevalo JF, Fromow-Guerra J, Sanchez JG, Maia M, Berrocal MH, Wu L, Saravia MJ, Costa RA, Pan-American Collaborative Retina Study Group.
    Retina; 2008 Feb; 28(10):1387-94. PubMed ID: 18827735
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Intravitreal bevacizumab (Avastin) injection in ocular ischemic syndrome.
    Amselem L, Montero J, Diaz-Llopis M, Pulido JS, Bakri SJ, Palomares P, Garcia-Delpech S.
    Am J Ophthalmol; 2007 Jul; 144(1):122-4. PubMed ID: 17601432
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 65.